CAS 914361-45-8
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte gefunden.
Fosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolate
Reinheit:≥95%Molekulargewicht:739.7g/molFosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolateFormel:C23H20F2N5O5PS·C6H14N2O2·C2H6OMolekulargewicht:739.734Fosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolate, a prodrug for ravuconazole, treats onychomycosis in Japan.Formel:C31H40F2N7O8PSReinheit:99.43%Farbe und Form:Yellow SolidMolekulargewicht:739.7Fosravuconazole L-lysine ethanolate
CAS:(S)-2,6-Diaminohexanoic acid (((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl dihydrogen phosphate and ethanol saltFormel:C31H40F2N7O8PSReinheit:97%Molekulargewicht:739.73Fosravuconazole L-Lysine Ethanolate-D₄
CAS:Kontrolliertes ProduktFormel:C23H16D4F2N5O5PS·C6H14N2O2·C2H6OFarbe und Form:NeatMolekulargewicht:743.8Fosravuconazole L-lysine ethanolate
CAS:Fosravuconazole L-lysine ethanolate is an antifungal prodrug, which is a derivative of the widely used antifungal agent ravuconazole. This compound is synthesized through chemical modification to enhance its bioavailability and aqueous solubility, addressing limitations found in its parent compound. Fosravuconazole is designed to undergo in vivo conversion to ravuconazole, its active form, by enzymatic processes within the body.
Formel:C31H40F2N7O8PSReinheit:Min. 95%Molekulargewicht:739.7 g/molFosravuconazole L-Lysine Ethanolate
CAS:Formel:C23H20F2N5O5PSC6H14N2O2C2H6OMolekulargewicht:547.47 : 146.2 : 46.1
